Macular Degeneration

14 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Retinal Degeneration, Retinal Diseases

Narrower: Geographic Atrophy 6, Stargardt Disease 3, Wet Macular Degeneration 1

Treatments and conditions

Macular Degeneration
Treatment and conditionWhere it standsTrials
ACDN-01 for stargardt diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
ADVM-022 for wet macular degenerationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Autologous iPSC-derived RPE for macular degenerationTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Eyecyte-RPE™ for geographic atrophyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
NT-101 ophthalmic solution for macular degenerationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU410 for geographic atrophyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OLN324 for macular degenerationTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
OpRegen for geographic atrophyPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
OpRegen for macular degenerationPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Prima for geographic atrophyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PRIMA Bionic Vision System for geographic atrophyTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
PRIMA Products for stargardt diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PST-611 for geographic atrophyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
SB-007 for stargardt diseasePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.